Deletion of the M6P/IGF2r gene in primary hepatocellular carcinoma

被引:41
|
作者
Piao, Z
Choi, Y
Park, C
Lee, WJ
Park, JH
Kim, H
机构
[1] YONSEI UNIV,COLL MED,DEPT PATHOL,SEOUL,SOUTH KOREA
[2] YONSEI UNIV,COLL MED,DEPT GEN SURG,SEOUL,SOUTH KOREA
[3] YONSEI UNIV,COLL MED,DEPT MICROBIOL,SEOUL,SOUTH KOREA
关键词
M6P/IGF2; receptor; hepatocellular carcinoma; tumor suppressor gene;
D O I
10.1016/S0304-3835(97)00289-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To evaluate the different alteration patterns of the mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2r) gene in hepatocellular carcinoma (HCC), 41 HCCs were screened for homozygous deletion and loss of heterozygosity (LOH) at the M6P/IGF2r gene with a dinucleotide repeat polymorphic marker. Of these, three (8.8%) were heterozygous and LOH was observed in two (66.7%) of these informative cases. Five (14.7%) out of 34 informative cases showed homozygous deletions for the dinucleotide repeat polymorphic marker. The frequent allelic loss and homozygous deletion of the M6P/IGF2r gene suggest that the M6P/IGF2r gene functions as a tumor suppressor gene in the development of HCC. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:39 / 43
页数:5
相关论文
共 50 条
  • [21] Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma
    Chang, Xian
    Lv, Yang-Fan
    He, Jing
    Cao, Ya
    Li, Chang-Qing
    Guo, Qiao-Nan
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 85 - 101
  • [22] p53 m6A modulation sensitizes hepatocellular carcinoma to apatinib through apoptosis
    Ke, Weiwei
    Zhang, Linlin
    Zhao, Xiangxuan
    Lu, Zaiming
    APOPTOSIS, 2022, 27 (5-6) : 426 - 440
  • [23] p53 m6A modulation sensitizes hepatocellular carcinoma to apatinib through apoptosis
    Weiwei Ke
    Linlin Zhang
    Xiangxuan Zhao
    Zaiming Lu
    Apoptosis, 2022, 27 : 426 - 440
  • [24] MiR-200a-3p Accelerated Hypoxia/Reoxygenation Injury in HCM Cells by Enhancing IGF2R via Wnt/β-catenin Signalling Pathway
    Ge, Yaolei
    Gao, Qun
    INTERNATIONAL JOURNAL OF HUMAN GENETICS, 2021, 21 (02) : 85 - 95
  • [25] Nitidine chloride inhibits the progression of hepatocellular carcinoma by suppressing IGF2BP3 and modulates metabolic pathways in an m6A-dependent manner
    Xiong, Dan-dan
    Chen, Zhen-dong
    Li, Jian-di
    Deng, Yu-long
    He, Rong-quan
    Huang, Zhi-guang
    An, San-qi
    Dang, Yi-wu
    Chen, Gang
    MOLECULAR MEDICINE, 2025, 31 (01)
  • [26] Alterations of tumour suppressor gene PPP2R1B in hepatocellular carcinoma
    Chou, Huei-Chi
    Chen, Chien-Hung
    Lee, Hsuan-Shu
    Lee, Cha-Ze
    Huang, Guan-Tarn
    Yang, Pei-Ming
    Lee, Po-Huang
    Sheu, Jin-Chuan
    CANCER LETTERS, 2007, 253 (01) : 138 - 143
  • [27] Abrogating the interplay between IGF2BP1, 2 and 3 and IGF1R by let-7i arrests hepatocellular carcinoma growth
    Fawzy, Injie Omar
    Hamza, Mohammed Tarif
    Hosny, Karim Adel
    Esmat, Gamal
    Abdelaziz, Ahmed Ihab
    GROWTH FACTORS, 2016, 34 (1-2) : 42 - 50
  • [28] ABERRATIONS OF TUMOR-SUPPRESSOR P53 GENE AND RETINOBLASTOMA GENE IN 2 CASES OF HEPATOCELLULAR-CARCINOMA ASSOCIATED WITH PRIMARY BILIARY-CIRRHOSIS
    MASUDA, T
    TAMURA, G
    SUZUKI, Y
    OIKAWA, H
    YAMAZAKI, K
    SUZUKI, K
    SATO, S
    SATODATE, R
    INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 1995, 3 (04): : 196 - 201
  • [29] TMEM241 is a UDP-N-acetylglucosamine transporter required for M6P modification of NPC2 and cholesterol transport
    Zhao, Nan
    Deng, Gang
    Yuan, Pei-Xin
    Zhang, Ya-Fen
    Jiang, Lu-Yi
    Zhao, Xiaolu
    Song, Bao-Liang
    JOURNAL OF LIPID RESEARCH, 2023, 64 (12)
  • [30] The expression of the mdm2 gene may be related to the aberration of the p53 gene in human hepatocellular carcinoma
    Qiu, SJ
    Ye, SL
    Wu, ZQ
    Tang, ZY
    Liu, YK
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1998, 124 (05) : 253 - 258